Leqvio 284 mg/1.5 ml is a prescription lipid-lowering medicine containing inclisiran. It is used in adults with primary hypercholesterolaemia or mixed dyslipidaemia as an adjunct to diet, either alongside other lipid-lowering treatment or in appropriate patients who cannot use statins.
Prescription medicine for subcutaneous administration by a healthcare professional only. The dose and treatment schedule must be determined and administered according to the prescribing physician's instructions.
Inclisiran is a small interfering RNA (siRNA) medicine that reduces production of PCSK9 in the liver. Reduced PCSK9 increases LDL receptor availability, helping lower circulating LDL cholesterol levels.
Each pre-filled syringe contains Inclisiran Sodium equivalent to 284 mg Inclisiran in 1.5 ml solution (189 mg/ml).
Water for injections, sodium hydroxide for pH adjustment and concentrated phosphoric acid for pH adjustment.
Helps reduce LDL cholesterol in eligible adults with primary hypercholesterolaemia or mixed dyslipidaemia when used as part of a medically supervised lipid-lowering treatment plan.
Solution for Subcutaneous Injection in Pre-Filled Syringe
284 mg / 1.5 ml
1 Pre-Filled Syringe
United Kingdom
KWD
